Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment.

Authors :: Del Re M
Addeo A
Passaro A
Petrini I
van Schaik RH
Danesi R
Source :: Pharmacogenomics [Pharmacogenomics] 2019 Dec; Vol. 20 (18), pp. 1255-1257.
Publication Year :: 2019

Subjects :: ErbB Receptors genetics
Humans
Lung Neoplasms drug therapy
Lung Neoplasms pathology
Mutation genetics
Protein Kinase Inhibitors therapeutic use
Biomarkers, Tumor blood
Circulating Tumor DNA blood
Lung Neoplasms blood

Full Text Access

Tools